Skip to Main Content

Author Details

Marco Skardelly
University Hospital Tubingen, Eberhard-Karls-University Tubingen
2002
79
23
PMIDPaper TitleJournal TitlePublished Year
36672508Correction: Gonçalves et al. Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort. <i>Cancers</i> 2021, <i>13</i>, 466.Cancers (Basel)2023
35838837The prognostic role of the immunohistochemical expression of S100 in meningiomas.J Cancer Res Clin Oncol2023
37171636Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.Acta Neuropathol2023
37335962Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial.J Clin Oncol2023
36915613Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system.Neurooncol Adv2023
34601710The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma.Neurosurg Rev2022
35599271Correction to: The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma.Neurosurg Rev2022
35558389Case Report: Posterolateral Epidural Supra-C2-Root Approach (PESCA) for Biopsy of a Retro-Odontoid Lesions in Same Sitting After Occipitocervical Fixation and Decompression in a Case of Crowned Dens Syndrome With Brainstem Compression and Displacement.Front Surg2022
33899156Differences in the expression of SSTR1-5 in meningiomas and its therapeutic potential.Neurosurg Rev2022
34890014GLINT: GlucoCEST in neoplastic tumors at 3 T-clinical results of GlucoCEST in gliomas.MAGMA2022
35251956Complete and Incomplete Resection for Progressive Glioblastoma Prolongs Post-Progression Survival.Front Oncol2022
34941573Tissue metabolites in diffuse glioma and their modulations by IDH1 mutation, histology, and treatment.JCI Insight2022
33104905The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy.Neurosurg Rev2021
33562558Dynamic Susceptibility Perfusion Imaging for Differentiating Progressive Disease from Pseudoprogression in Diffuse Glioma Molecular Subtypes.J Clin Med2021
33530441Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort.Cancers (Basel)2021
34966669A Continuous Correlation Between Residual Tumor Volume and Survival Recommends Maximal Safe Resection in Glioblastoma Patients: A Nomogram for Clinical Decision Making and Reference for Non-Randomized Trials.Front Oncol2021
34781889Prognostic value of tumour volume in patients with a poor Karnofsky performance status scale - a bicentric retrospective study.BMC Neurol2021
34800210Increased proliferation is associated with CNS invasion in meningiomas.J Neurooncol2021
34129129Correction to: Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes.Neurol Sci2021
34122231Hope and Distress Are Not Associated With the Brain Tumor Stage.Front Psychol2021
34172069Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy.Radiat Oncol2021
33367841H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort.Neuro Oncol2021
32462389Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes.Neurol Sci2020
33898054FGFR3 overexpression is a useful detection tool for FGFR3 fusions and sequence variations in glioma.Neurooncol Pract2020
33287241CNS Invasion in Meningioma-How the Intraoperative Assessment Can Improve the Prognostic Evaluation of Tumor Recurrence.Cancers (Basel)2020
29468261In Vivo Molecular Profiling of Human Glioma : Cross-Sectional Observational Study Using Dynamic Susceptibility Contrast Magnetic Resonance Perfusion Imaging.Clin Neuroradiol2019
31358024Integrative assessment of brain and bone invasion in meningioma patients.Radiat Oncol2019
31291992COX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intake.Acta Neuropathol Commun2019
31231853T1ρ-based dynamic glucose-enhanced (DGEρ) MRI at 3 T: method development and early clinical experience in the human brain.Magn Reson Med2019
30777204Diffusion kurtosis imaging histogram parameter metrics predicting survival in integrated molecular subtypes of diffuse glioma: An observational cohort study.Eur J Radiol2019
30733620Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma.Nature2019
31089718Regorafenib in advanced high-grade glioma: a retrospective bicentric analysis.Neuro Oncol2019
30606066Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis.Immunotherapy2019
30568303Actively personalized vaccination trial for newly diagnosed glioblastoma.Nature2019
30610375High frequency of H3 K27M mutations in adult midline gliomas.J Cancer Res Clin Oncol2019
28786347KCa3.1 Channels and Glioblastoma: In Vitro Studies.Curr Neuropharmacol2018
29864573Overshunting-Associated Myelopathy (OSAM) in a Patient with Bilateral Jugular Vein Occlusion.World Neurosurg2018
30238395Survey of the management of perioperative bridging of anticoagulation and antiplatelet therapy in neurosurgery.Acta Neurochir (Wien)2018
30627156High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma.Int J Endocrinol2018
28488024Glioma Grading and Determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion.Clin Neuroradiol2018
29667086Contrast enhancement predicting survival in integrated molecular subtypes of diffuse glioma: an observational cohort study.J Neurooncol2018
29464269Glioma grading by dynamic susceptibility contrast perfusion and <sup>11</sup>C-methionine positron emission tomography using different regions of interest.Neuroradiology2018
29232820In Reply to the Letter to the Editor Regarding "The Prognostic Impact of Ventricular Opening in Glioblastoma Surgery: A Retrospective Single Center Analysis".World Neurosurg2018
29053887Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas.Neuropathol Appl Neurobiol2018
28702832Effect of Perfusion on Diffusion Kurtosis Imaging Estimates for In Vivo Assessment of Integrated 2016 WHO Glioma Grades : A Cross-Sectional Observational Study.Clin Neuroradiol2018
28865921In vivo assessment of tumor heterogeneity in WHO 2016 glioma grades using diffusion kurtosis imaging: Diagnostic performance and improvement of feasibility in routine clinical practice.J Neuroradiol2018
28025828Prognostic parameters and outcome after re-irradiation for progressive glioblastoma.Acta Neurol Scand2017
28360216Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma.Oncologist2017
28987669Histogram analysis of diffusion kurtosis imaging estimates for in vivo assessment of 2016 WHO glioma grades: A cross-sectional observational study.Eur J Radiol2017
28729143The Prognostic Impact of Ventricular Opening in Glioblastoma Surgery: A Retrospective Single Center Analysis.World Neurosurg2017
  • 1 - 50 of 79

Recommended Authors

Barbara Kiesel
Medical University of Vienna
Career Start Year 2012
Number of shared co-authors 3
Johannes Kerschbaumer
Medical University of Innsbruck
Career Start Year 2012
Number of shared co-authors 1
Christian F Freyschlag
Medical University of Innsbruck
Career Start Year 2010
Number of shared co-authors 1
Jenny Kan-Suen Pu
Queen Mary Hospital
Career Start Year 2009
Number of shared co-authors 2
Rohan Ramakrishna
Weill Cornell Medical College, New York Presbyterian Hospital
Career Start Year 2009
Number of shared co-authors 6
Adelheid Woehrer
Medical University of Vienna
Career Start Year 2008
Number of shared co-authors 6
Yoshua Esquenazi
McGovern Medical School at UT Health Houston
Career Start Year 2007
Number of shared co-authors 0
Nancy Ann Oberheim Bush
University of California san francisco
Career Start Year 2005
Number of shared co-authors 5
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Matthias Preusser
Medical University of Vienna
Career Start Year 2003
Number of shared co-authors 10
Ichiyo Shibahara
Kitasato University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
Martin Glas
University Hospital Essen
Career Start Year 2002
Number of shared co-authors 7
Andrew P Morokoff
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 0
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2001
Number of shared co-authors 1
Thomas Roetzer
Medical University of Vienna
Career Start Year 2000
Number of shared co-authors 3
Chul-Kee Park
College of Medicine, Seoul National University
Career Start Year 2000
Number of shared co-authors 4
Radim Jancalek
St. Anne University Hospital, Masaryk University
Career Start Year 1999
Number of shared co-authors 1
Franz Marhold
Karl Landsteiner University of Health Sciences
Career Start Year 1998
Number of shared co-authors 1
Manish K Aghi
University of California san francisco
Career Start Year 1997
Number of shared co-authors 3
John A Boockvar
Lenox Hill Hospital
Career Start Year 1997
Number of shared co-authors 0
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Career Start Year 1996
Number of shared co-authors 7
Clark C Chen
University of Minnesota
Career Start Year 1994
Number of shared co-authors 7
Howard Colman
Huntsman Cancer Institute, University of Utah
Career Start Year 1990
Number of shared co-authors 8
Tom Mikkelsen
Ontario Brain Institute
Career Start Year 1990
Number of shared co-authors 6
Georg Widhalm
Medical University of Vienna
Career Start Year 1988
Number of shared co-authors 6
Michael Weller
University Hospital and University of Zurich
Career Start Year 1987
Number of shared co-authors 14
Ryo Nishikawa
Saitama Medical University International Medical Center
Career Start Year 1986
Number of shared co-authors 3
Michael A Vogelbaum
Moffit Cancer Center
Career Start Year 1986
Number of shared co-authors 11
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 7
Mitchel S Berger
University of California san francisco
Career Start Year 1982
Number of shared co-authors 6

Collaborators

Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Co-authored papers 44
Marcos Tatagiba
University of Tubingen
Co-authored papers 30
Felix Behling
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Co-authored papers 26
David Capper
Charite University Medicine Berlin
Co-authored papers 3
Peter Martus
Eberhard Karls University of Tuebingen
Co-authored papers 2
Jordi Rodon
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Saskia Biskup
Center for Genomics and Transcriptomics (CeGaT)
Co-authored papers 2
Andreas von Deimling
Co-authored papers 2
Hideho Okada
Co-authored papers 2
Juan Sahuquillo
Vall d'Hebron University Hospital
Co-authored papers 2
Arie Admon
Co-authored papers 2
Arnulf Stenzl
Eberhard Karls University of Tubingen
Co-authored papers 1
Benedikt Wiestler
Technical University
Co-authored papers 1
Julia Furtner
Medical University of Vienna
Co-authored papers 1
Felix Sahm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 1
Andrew Gao
University Health Network
Co-authored papers 1
Helin Dogan
University Hospital Heidelberg (DKFZ)
Co-authored papers 1
Oliver Kohlbacher
Max Planck Institute for Developmental Biology
Co-authored papers 1
Kenneth Aldape
National Cancer Institute
Co-authored papers 1
Lars Zender
Co-authored papers 1
Rebecca Yakubov
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers 1
Sebastian Brandner
UCL Queen Square Institute of Neurology
Co-authored papers 1
Aaron A Cohen-Gadol
Indiana University
Co-authored papers 1
David R Raleigh
University of California san francisco
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Farshad Nassiri
Toronto Western Hospital, University Health Network, University of Toronto
Co-authored papers 1
Jill S Barnholtz-Sloan
National Cancer Institute
Co-authored papers 1
Stephan Ossowski
Institute of Medical Genetics and Applied Genomics, University of Tubingen
Co-authored papers 1
Elgin Hoffman
Eberhard Karls University Tubingen
Co-authored papers 1
Gelareh Zadeh
University of Toronto
Co-authored papers 1
Release 1.2